These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31008686)

  • 41. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.
    Nandhikonda P; Yasgar A; Baranowski AM; Sidhu PS; McCallum MM; Pawlak AJ; Teske K; Feleke B; Yuan NY; Kevin C; Bikle DD; Ayers SD; Webb P; Rai G; Simeonov A; Jadhav A; Maloney D; Arnold LA
    Biochemistry; 2013 Jun; 52(24):4193-203. PubMed ID: 23713684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
    Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High sugar intake and development of skeletal muscle insulin resistance and inflammation in mice: a protective role for PPAR- δ agonism.
    Benetti E; Mastrocola R; Rogazzo M; Chiazza F; Aragno M; Fantozzi R; Collino M; Minetto MA
    Mediators Inflamm; 2013; 2013():509502. PubMed ID: 23861559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
    Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
    Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GW0742, a high affinity PPAR-β/δ agonist reduces lung inflammation induced by bleomycin instillation in mice.
    Galuppo M; Di Paola R; Mazzon E; Esposito E; Paterniti I; Kapoor A; Thiemermann C; Cuzzocrea S
    Int J Immunopathol Pharmacol; 2010; 23(4):1033-46. PubMed ID: 21244753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-regulated gene dosage effect of PPARα on synaptic plasticity.
    Pierrot N; Ris L; Stancu IC; Doshina A; Ribeiro F; Tyteca D; Baugé E; Lalloyer F; Malong L; Schakman O; Leroy K; Kienlen-Campard P; Gailly P; Brion JP; Dewachter I; Staels B; Octave JN
    Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30894406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.
    Batista FA; Trivella DB; Bernardes A; Gratieri J; Oliveira PS; Figueira AC; Webb P; Polikarpov I
    PLoS One; 2012; 7(5):e33643. PubMed ID: 22606221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deficits in hippocampal neurogenesis in obesity-dependent and -independent type-2 diabetes mellitus mouse models.
    Bonds JA; Shetti A; Stephen TKL; Bonini MG; Minshall RD; Lazarov O
    Sci Rep; 2020 Oct; 10(1):16368. PubMed ID: 33004912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
    Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
    J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells.
    Shan J; Kimura H; Yokoi S; Kamiyama K; Imamoto T; Takeda I; Kobayashi M; Mikami D; Takahashi N; Kasuno K; Sugaya T; Iwano M
    Clin Exp Nephrol; 2021 Jun; 25(6):598-607. PubMed ID: 33646450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.
    Ren T; Liu J; Ge Y; Zhuo R; Peng L; Liu F; Jin X; Yang L
    Neurochem Int; 2019 Oct; 129():104501. PubMed ID: 31299417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired spatial navigation and age-dependent hippocampal synaptic dysfunction are associated with chronic inflammatory response in db/db mice.
    Al-Onaizi M; Al-Sarraf A; Braysh K; Kazem F; Al-Hussaini H; Rao M; Kilarkaje N; ElAli A
    Eur J Neurosci; 2022 Dec; 56(11):6003-6021. PubMed ID: 36226387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early onset of cognitive impairment is associated with altered synaptic plasticity and enhanced hippocampal GluA1 expression in a mouse model of depression.
    Gross M; Sheinin A; Nesher E; Tikhonov T; Baranes D; Pinhasov A; Michaelevski I
    Neurobiol Aging; 2015 May; 36(5):1938-52. PubMed ID: 25796132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
    Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
    Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Gross B; Staels B
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):687-710. PubMed ID: 18054742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.